We are live on ! Find out more
HVC

Healthcare Value Capital Portfolio holdings

AUM $50.7M
1-Year Est. Return 24.72%
This Fund
S&P 500
This Quarter Est. Return
+10.02%
1 Year Est. Return
+24.72%
3 Year Est. Return
+18.99%
5 Year Est. Return
+98.49%
10 Year Est. Return
–
AUM
$44.9M
AUM Growth
+$15.2M
Cap. Flow
+$10.3M
Cap. Flow %
23.01%
Top 10 Hldgs %
66.25%
Holding
28
New
11
Increased
3
Reduced
2
Closed
6

Top Buys

Rank Stock Value
1
PFE icon
Pfizer
PFE
+$3.55M
2
COLL icon
Collegium Pharmaceutical
COLL
+$2.38M
3
AMYT
Amryt Pharma plc American Depositary Shares
AMYT
+$2.17M
4
IRWD icon
Ironwood Pharmaceuticals
IRWD
+$2.11M
5
ALKS icon
Alkermes
ALKS
+$2.05M

Top Sells

Rank Stock Value
1
ABBV icon
AbbVie
ABBV
+$3.75M
2
MCK icon
McKesson
MCK
+$1.74M
3
JAZZ icon
Jazz Pharmaceuticals
JAZZ
+$1.65M
4
TYME
Tyme Technologies, Inc. Common Stock
TYME
+$1.4M
5
CAH icon
Cardinal Health
CAH
+$1.34M

Sector Composition

Rank Sector Weight
1 Healthcare 84.3%
2 Miscellaneous 12.75%
3 Consumer Staples 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GILD icon
1
Gilead Sciences
GILD
$185B
$4.85M 10.8%
75,000
+25,000
+50% +$1.61M
PFE icon
2
Pfizer
PFE
$160B
$3.62M 8.07%
+100,000
New +$3.55M
GSK icon
3
GSK
GSK
$101B
$3.57M 7.95%
80,000
– –
CLVS
4
DELISTED
Clovis Oncology, Inc.
CLVS
$3.16M 7.04%
450,000
+200,000
+80% +$1.34M
YARW
5
Yarrow Bioscience
YARW
$104M
$2.74M 6.1%
444
-112
-20% -$812K
TYME
6
DELISTED
Tyme Technologies, Inc. Common Stock
TYME
$2.67M 5.95%
1,500,000
-675,000
-31% -$1.4M
COLL icon
7
Collegium Pharmaceutical
COLL
$818M
$2.37M 5.28%
+100,000
New +$2.38M
SPXU icon
8
CALL
ProShares UltraPro Short S&P 500
SPXU
$384M
$2.37M 5.27%
+5,000
New +$2.65M
IRWD icon
9
Ironwood Pharmaceuticals
IRWD
$702M
$2.24M 4.98%
+200,000
New +$2.11M
AMYT
10
DELISTED
Amryt Pharma plc American Depositary Shares
AMYT
$2.17M 4.83%
+155,555
New +$2.17M
ATRS
11
DELISTED
Antares Pharma, Inc.
ATRS
$2.06M 4.58%
500,000
– –
ALKS icon
12
Alkermes
ALKS
$8.2B
$1.87M 4.16%
+100,000
New +$2.05M
AMRN
13
CALL
Amarin Corp
AMRN
$297M
$1.86M 4.15%
15,000
– –
BMY icon
14
Bristol-Myers Squibb
BMY
$137B
$1.58M 3.51%
+25,000
New +$1.56M
MRK icon
15
Merck
MRK
$369B
$1.54M 3.43%
+20,960
New +$1.55M
GNLN icon
16
Greenlane Holdings
GNLN
$1.95M
– –
0
– –
AUPH icon
17
Aurinia Pharmaceuticals
AUPH
$2.19B
$1.3M 2.89%
+100,000
New +$1.45M
AZN icon
18
AstraZeneca
AZN
$255B
$1.24M 2.77%
+12,500
New +$1.26M
VIXY icon
19
CALL
ProShares VIX Short-Term Futures ETF
VIXY
$212M
$935K 2.08%
1,250
+625
+100% +$639K
IRWD icon
20
CALL
Ironwood Pharmaceuticals
IRWD
$702M
$559K 1.25%
+50,000
New +$528K
ADMS
21
DELISTED
Adamas Pharmaceuticals
ADMS
$480K 1.07%
100,000
– –
GMDA
22
DELISTED
Gamida Cell Ltd. Ordinary Shares
GMDA
$405K 0.9%
50,000
– –
ABBV icon
23
AbbVie
ABBV
$456B
– –
-35,000
Closed -$3.75M
CAH icon
24
Cardinal Health
CAH
$54.6B
– –
-25,000
Closed -$1.34M
JAZZ icon
25
Jazz Pharmaceuticals
JAZZ
$16.3B
– –
-10,000
Closed -$1.65M
1
2

Similar funds

C
Castlelake Minneapolis, Minnesota $48.5M AUM 87.77% 1-Year Est. Return
CC
Cedar Capital Barrington, Illinois $54.9M AUM 33.3% 1-Year Est. Return
FCOI
FirstMark Capital OF II New York $44.1M AUM 18.15% 1-Year Est. Return
FCOI
FirstMark Capital OF I New York $43.1M AUM 6.31% 1-Year Est. Return
BI
BCBSM Inc Eagan, Minnesota $42.4M AUM 0.4% 1-Year Est. Return
KC
Kelso & Company New York $42.3M AUM
SCIM
Spring Creek Investment Management Philadelphia, Pennsylvania $42.3M AUM 31.86% 1-Year Est. Return
MCP
Moab Capital Partners Southampton, New York $41M AUM 33.21% 1-Year Est. Return

Healthcare Value Capital's Q1 2021 Portfolio in Review

As of Q1 2021, Healthcare Value Capital held 28 positions worth $44.9M, up 51% from $29.7M the previous quarter. Its ten largest holdings account for 66% of the portfolio.

Healthcare Value Capital deployed $10.3M of net new capital in Q1 2021, opening 11 new positions and adding to 3 existing holdings. Its largest new stake was Pfizer: 100,000 shares worth $3.62M.

By sector, the portfolio is most concentrated in Healthcare at 84% of assets, up from 84% a quarter earlier, followed by Miscellaneous and Consumer Staples.

On the sell side, the largest reduction was Tyme Technologies, Inc. Common Stock, an estimated $1.4M trimmed.

  • Healthcare Value Capital's largest Q1 2021 buy was Pfizer: 100,000 shares worth $3.62M.
  • Healthcare Value Capital added most to Gilead Sciences in Q1 2021, an estimated $1.61M increase.
  • Healthcare Value Capital's biggest Q1 2021 reduction was Tyme Technologies, Inc. Common Stock, cutting an estimated $1.4M.
  • Healthcare Value Capital fully exited AbbVie in Q1 2021, selling an estimated $3.75M.
  • Healthcare Value Capital's ten largest holdings make up 66% of its $44.9M portfolio in Q1 2021.
  • Healthcare Value Capital opened 11 new positions and closed 6 in Q1 2021.
  • Healthcare Value Capital's portfolio value rose 51% quarter-over-quarter to $44.9M.

Based on Healthcare Value Capital's 13F filing for Q1 2021, filed 17 May 2021.